[Form 4] The Charles Schwab Corporation Insider Trading Activity
Rhea-AI Filing Summary
Charles Schwab Corporation (SCHW) – Form 4 insider filing
On 07/01/2025, independent director Charles A. Ruffel received a non-qualified stock option for 1,322 shares of Charles Schwab common stock at an exercise price of $91.17. The option was granted under the company’s Directors’ Deferred Compensation Plan II, vests immediately, and expires on 07/01/2035. The award was taken in lieu of cash director fees, indicating the director’s choice to align compensation with future share performance. Following the grant, Mr. Ruffel beneficially owns 1,322 derivative securities (options) directly; no changes were reported in his non-derivative (common-stock) holdings.
The transaction is routine board compensation and does not involve open-market purchases or sales. While it marginally increases insider exposure to the stock, the small size (≈$120k notional value at grant price) suggests limited market impact.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director accepted 1,322 options instead of cash; routine, low-value, low market impact.
The filing shows an automatic grant under Schwab’s deferred compensation plan: 1,322 NQSOs, strike $91.17, 10-year term, immediate vesting. This is standard board compensation, amounting to roughly 0.00007% of shares outstanding and less than 0.1% of daily trading volume, so liquidity or signaling effects are negligible. Nonetheless, choosing equity over cash modestly tightens board-shareholder alignment. No sales were disclosed, eliminating concerns about negative insider sentiment. Overall, the event is neutral to valuation and should not alter investment theses.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Nonqualified Stock Option (right to buy) | 1,322 | $0.00 | -- |
Footnotes (1)
- The option was received pursuant to the Directors' Deferred Compensation Plan II and vests immediately. The option was received in lieu of cash compensation otherwise payable as director fees.